-
Samuel, N, Wilson, G, Lemire, M, Id Said, B, Lou, Y, Li, W, Merino, D, Novokmet, A, Tran, J, Nichols, KE, et al.
Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer Susceptibility..
J Clin Oncol
34(30)
:
3697 -3704
2016
view publication
-
Kieran, MW, Bouffet, E, Tabori, U, Broniscer, A, Cohen, K, Hansford, J, Geoerger, B, Hingorani, P, Dunkel, I, Russo, M, et al.
LBA19_PR CNS tumours The first study of dabrafenib in pediatric patients with BRAF V600–mutant relapsed or refractory low-grade gliomas.
Annals of Oncology
27:
vi557
2016
view publication
-
Bouffet, E, Larouche, V, Campbell, BB, Merico, D, de Borja, R, Aronson, M, Durno, C, Krueger, J, Cabric, V, Ramaswamy, V, et al.
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency..
J Clin Oncol
34(19)
:
2206 -2211
2016
view publication
-
Dodgshun, AJ, SantaCruz, N, Hwang, J, Ramkissoon, SH, Malkin, H, Bergthold, G, Manley, P, Chi, S, MacGregor, D, Goumnerova, L, et al.
Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation..
J Neurooncol
128(2)
:
293 -302
2016
view publication
-
Campbell, B, Bouffet, E, Larouche, V, Mason, G, Reddy, A, Osborn, M, Magimairan, V, Merico, D, de Borja, R, Chung, B, et al.
HG-53HYPERMUTATION AND NEOANTIGEN FORMATION PREDICT RESPONSE TO IMMUNE CHECKPOINT INHIBITION IN CHILDHOOD BIALLELIC MISMATCH REPAIR DEFICIENT GLIOBLASTOMA.
Neuro-Oncology
18(suppl_3)
:
iii59 -iii60
2016
view publication